XBI241227C81000
- 0.00
- 0.000.00%
SPDR S&P Biotech ETF Newsroom
Top U.S. Health Care Mid-cap Stocks and Their Quant Ratings
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Why Did Pfizer's Exit From the Gene Therapy Program Hit Sangamo Hard?
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
Annual Review | The most powerful month saw a threefold increase! Looking back at the monthly explosive rise of US stocks in 2024, AI and Trump Trade swept the whole year, with three Stocks making the list twice.
The US stock market continues to rise in 2024, mainly due to two significant trends: the tech stock frenzy driven by the AI boom and Trump's return to the White House.
Global enterprises are "fully powered" to borrow money! The scale will reach 8 trillion dollars in 2024, setting a record.
Bankers stated that low financing costs were the initial reason for companies to choose to issue Bonds early, as they wanted to avoid the market volatility risks that could arise around the USA elections. However, after Trump's election victory, the market's credit spreads further narrowed, prompting some companies to decide to lock in their borrowing needs for the following year in order to secure funds under favorable market conditions.
Year-end review of the US stock market: The seven giants continue to surge, and investors prepare for Trump 2.0.
In 2024, the US stock market is driven by the AI boom, the Federal Reserve's interest rate cuts, and strong economic growth, with the three major indices reaching new highs: the S&P 500 Index up 25% for the year, the Nasdaq Composite Index up 31% for the year, and the Dow Jones up 14% for the year; following Trump's return, a series of policies are expected to create huge waves, and the Federal Reserve's comments indicating a slowdown in interest rate cuts have already disturbed the market.
Here Are Morgan Stanley's Key Oncology Catalysts for 2025
Looking At Amgen's Recent Unusual Options Activity
Medical stocks welcome a rebound opportunity: three major star companies may become investment highlights in 2025.
In 2024, the performance of the Medical Industry is disappointing for investors, but 2025 may bring a glimmer of hope.
Top Dividend Picks for 2025 According to Seeking Alpha's Quant Metrics
10 Health Care Stocks With Whale Alerts In Today's Session
Assembly Bio Spikes After Early-stage Data for Gilead-partnered Hep B Therapy
Looking Into AbbVie's Recent Short Interest
$100 Invested In AbbVie 5 Years Ago Would Be Worth This Much Today
How Is The Market Feeling About Alnylam Pharmaceuticals?
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Spotlight on Amgen: Analyzing the Surge in Options Activity
SPDR S&P Biotech ETF Declares Quarterly Distribution of $0.0027
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?